The mammary gland of laboratory rodents is an important organ for the evaluation of effects of xenobiotics, especially those that perturb hormonal homeostasis or are potentially carcinogenic. Mammary gland cancer is a leading cause of human mortality and morbidity worldwide and is a subject of major research efforts utilizing rodent models. Zymbal's, preputial, and clitoral glands are standard tissues that are evaluated in animal models that enable human risk assessment of xenobiotics. A widely accepted and utilized international harmonization of nomenclature for mammary, Zymbal's, preputial, and clitoral gland lesions in laboratory animals will improve diagnostic alignment among regulatory and scientific research organizations and enrich international exchanges of information among toxicologists and pathologists.
INTRODUCTION
The INHAND Project (International Harmonization of Nomenclature and Diagnostic Criteria for Lesions in Rats and Mice) is a joint initiative of the Societies of Toxicologic Pathology from Europe (ESTP), Great Britain (BSTP), Japan (JSTP), and North America (STP) to develop an internationally accepted nomenclature for proliferative and nonproliferative lesions in laboratory animals. The purpose of this publication is to provide a standardized nomenclature for classifying proliferative and nonproliferative lesions observed in the mammary, Zymbal's, preputial, and clitoral glands of laboratory rats and mice. The diagnostic terminology and criteria described here is based in part on the standardized nomenclature for proliferative mammary gland changes (Mann et al. 1996) in rats published previously by the STP and World Health Organization (WHO). The recommended standardized nomenclature of mammary, Zymbal's, preputial, and clitoral gland lesions presented in this document is also available electronically at the goRENI website on the Internet (http://www.goreni.org/). While our charge and primary goal has been to provide a morphology-based terminology applicable to the rat and mouse, the extended scientific community is working toward the harmonization of nomenclature and diagnostic criteria across species and man. This is born of the genomic revolution and the one gene, one medicine concept that now permeates medicine and is in part being actualized using the genetic engineered mouse (GEM). Clearly, ''harmonization'' will come through genomics. The molecules that are associated with breast and other cancers in humans are also likely to be associated with cancers in the same organ in mice (and rats). The molecular biologists are proving that the entire gene expression pattern of these tumors in mice match closely that of different classes of human breast cancers. The GEM models of human breast cancer are creating tumor phenotypes that have never been seen in spontaneous or carcinogen-induced mouse mammary tumors, some of which are also morphologically similar to human cancers. An entirely new nomenclature will be required to accommodate these newly created animals. The nomenclature will need to begin with the molecule and include the microscopic anatomy. Although the ''mapping'' of these terms across species is not complete (Table 1) , the toxicological pathology community will have increasing contact with these newly created animals. We will need to be familiar with their pathology and will need to understand their similarities to and difference from their human counterparts. For this reason, throughout this publication there has been an attempt to incorporate the emerging data from GEM models as it relates to nomenclature and diagnostic criteria.
The mammary gland of laboratory rodents is an important organ for the evaluation of effects of xenobiotics, especially those that perturb hormonal homeostasis or are potentially carcinogenic. Mammary gland cancer is a leading cause of human mortality and morbidity worldwide (Siegel et al. 2012) and is a subject of major research efforts utilizing rodent models (Cardiff et al. 2000) . Zymbal's, preputial, and clitoral glands are standard tissues that are evaluated in animal models that enable human risk assessment of xenobiotics. A widely accepted and utilized international harmonization of nomenclature for mammary, Zymbal's, preputial, and clitoral gland lesions in laboratory animals will decrease confusion among regulatory and scientific research organizations in different countries and will provide a common language to increase and enrich international exchanges of information among toxicologists and pathologists.
Mammary glands are standard tissues collected in all Good Laboratory Practices (GLP) and many non-GLP rodent toxicology studies. In rodent studies, all gross lesions are collected, and routinely, the inguinal (5th) mammary gland pair is dissected with or without skin and local lymph nodes from the same side in both sexes. Usually the mammary gland is trimmed in cross or transverse section. It is recommended that the mammary gland is cut in longitudinal (frontal) sections to allow for a greater chance of detecting treatment-related effects. Using frontal sectioning allows for a greater area of the mammary epithelia to be evaluated. Unless testing a specific hypothesis, toxicological pathologists will not generally use mammary gland genomic or immunohistochemistry (IHC) markers in oncogenicity studies because they are by design survey studies. However, if treatment-related changes are observed, molecular pathology techniques may be very useful in risk assessment. The assessment of the mammary gland should always be done in concert with histologic evaluation of the hypothalamic-pituitary-gonadal axis, the adrenal gland, and other end organs such as the prostate, the preputial, and the clitoral glands.
Proliferative lesions in laboratory rodents may arise from genotoxic or infectious agents or changes in hormonal The names ductal and lobular are clinically used to describe morphological patterns. However, they do not describe cell origin, as both tumor types originate in the TDLU, and should be better used in the context of ''ductal or lobular differentiation'' rather than ''ductal or lobular origin'' (Cardiff and Wellings: 1999. c The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer (Lanari et al. 2009). d Type P are the pregnancy-dependent tumors in Gr and RIII mouse strains that progress to hormone independence.
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RUDMANN ET AL. TOXICOLOGIC PATHOLOGY homeostasis as part of the aging process or experimentally as a result of genetic engineering, but the most important proliferative mammary gland lesions are caused by exposure to potentially toxic test materials that affect hormonal homeostasis or cause cellular damage. Cellular damage from repeated exposure to toxicants induces a repair process in which the damaged tissue, if return to normal morphology is not complete, may continue to proliferate (hyperplasia or neoplasia), and/or undergo metaplasia to a different, more resistant cell type. The site of these changes is heavily dependent upon the nature of the toxicant and the type of tissue exposed. Nonproliferative lesions in general are also associated with experimental perturbation or are a result of degenerative changes frequently associated with aging. Modern laboratory animal management practices within rodent facilities are such that spontaneous infectious processes should be infrequently encountered; thus the lesions related to infectious diseases are not described in detail in this document. For both proliferative and nonproliferative lesions, genetic engineering in an animal may also result in a model with novel and important lesions that require consistent terminology across laboratories and descriptions that aid in translation to human disease. These are described or referenced in this document.
GEM MODELS
Genetic engineering of mice has introduced literally hundreds of new mouse models of human breast cancer. The new models can be divided into four categories: Mouse models that (1) recapitulate spontaneous and chemically induced models;
(2) develop unique genotype-specific ''signature'' phenotypes;
(3) mimic human morphological phenotypes; and (4) simulate human genotypes or molecular phenotypes (Cardiff, Munn, and Galvez 2006) .
Mouse Models that Recapitulate Spontaneous and Chemically Induced Mouse Models
Virus-induced tumors. Activation of mouse DNA by integration of mouse mammary tumor virus (MMTV) is the primary mutagenic event leading to ''spontaneous'' mouse mammary tumors. The original descriptions by Apolant (1906) and Haaland (1911) are based on ''spontaneous'' tumors induced by MMTV as well as that from Dunn (1959) . Molecular analysis revealed that most of these tumors have activation of wnt, fibroblast growth factor (FGF), and/or notch. Interestingly, when mice were specifically engineered using molecular constructs containing wnt or FGF behind the MMTV-LTR promoter, they developed Type A, Type B, or Type P tumors (Sass and Dunn 1979) . Equally important, activation of one oncogene, such as wnt, resulted in co-activation of the other complementary oncogene, such as FGF (van Leeuwen and Nusse 1995) . MMTV is mouse-specific; therefore, while these models are useful for investigating the potential roles of different tumor suppressor and oncogenes in the pathogenesis of mammary gland neoplasms, the activation or suppression of DNA by MMTV itself is not applicable to human tumorigenesis.
Chemically induced tumors. A limited number of chemically induced tumors have been analyzed; common carcinogens such as 7,12-dimethylbenz [a]anthracene (DMBA) or 3-methylcholanthrene (MCA) result in mutational activation of the H-ras gene (Cardiff et al. 2000) frequently originating keratoacanthomas or adenosquamous carcinomas with squamous metaplasia (Currier et al. 2005) . The tumors with squamous metaplasia have activation of the wnt-APC-B-Catenin pathway (Tsukamoto et al. 1988; Gaspar et al. 2009; Michaelson and Leder 2001) . Other tumor types have not been analyzed.
Mouse Models that Develop Unique Genotype-specific ''Signature'' Phenotypes
Most GEM develop tumor phenotypes that never have been previously seen in the mouse. The key observation is that most oncogene activation results in tumors with gene-specific signature phenotypes and oncogene activation from the same pathway results in tumors with similar phenotypes (Rosner et al. 2002) . For example, the myc, ras, and neu tumor phenotypes are unique and distinguishable (Cardiff et al. 2000) . Tg(Myc) mice develop tumors with large pleomorphic nuclei and coarse chromatin with abundant amphophilic cytoplasm resembling a mammary counterpart to Burkitt's lymphoma. Tg(Ras) tumors form papillary structures with small cells with oval nuclei and red cytoplasm (Sinn et al. 1987) , resembling human transitional cell carcinomas of the urinary bladder. The Tg(cNeu) tumors tend to be solid nodules with intermediate sized nuclei and light pink-orange cytoplasm (Muller et al. 1988; Komitowski,Sass, and Laub 1982) . With central necrosis, they resemble human comedo-carcinomas. Mutation of other molecules in the Wnt pathway, such as APC or B-catenin results in tumors with similar morphologies (Gaspar et al. 2009 ). These phenotypes may be primarily based on cytological characteristics, as a recent study of Tg(Myc) with different mutations share cytological characteristics but different histological patterns (Andrechek et al. 2009 ).
In another example, mammary tumors in Tm(PTEN À/À ) mice characteristically are adenomyoepitheliomas (Stambolic et al. 2000) , also characteristic of the closely related mutant PIK3 mice (Meyer et al. 2011) . No molecular studies of sporadic, spontaneous adenomyoepitheliomas have been performed. The Epithelial-Mesenchymal-Transition (EMT) tumor phenotype (Cardiff 2010; Radaelli, Damonte, and Cardiff 2009 ) is a special type that has been previously recognized as a carcinosarcomas (Barnes et al. 2005) . In GEM, EMT occurs in the context of loss of the expression of the initiating oncogene and p53 mutations (Debies et al. 2008) . Such tumors have a range of phenotypes ranging from a mixed adenocarcinoma and spindle Vol. 40, No. 6S, 2012 DIAGNOSTIC TERMINOLOGY OF THE MAMMARY GLAND 9S cell tumor to a pure spindle cell tumor (Damonte et al. 2007) . EMT is most easily verified using the criteria of dual staining with mesenchymal and epithelial markers (Damonte et al. 2007 ). Some observers have speculated that these are metaplastic carcinomas. However, molecular evidence to support this hypothesis is lacking. There are numerous additional examples; further discussion is beyond the scope of this article.
Mouse Tumors that Mimic the Histopathology of Human Tumors
With genetic engineering, numerous candidate oncogenes have been tested by targeting the mouse mammary gland using molecular modification (Borowsky 2011). Tumors that most closely resemble their human counterparts include the Tg(c-ErbB2) and Tm(CDN1 À/À xp53 À/À ). Many Tg(c-ErbB2) tumors resemble their human counterparts that overexpress this same gene (Bouchard et al. 1989; Ursini-Siegel et al. 2007 ). The Tm(CDN1 À/À xp53 À/À ) tumors have the typical single file configuration of human lobular carcinoma, which is also associated with loss of E-Cadherin (CDN1) (Derksen et al. 2006 ). The Tm(Stat1 À/ ) is the first GEM model with uniformly ERþ, PRþ, FoxA1þ neoplasms that have experimentally proven ovarian dependence and that mimics the histopathology of some luminal A tumors (Chan et al. 2012) .
Mouse Models and Molecular Classifications
The traditional morphology-based classification of human breast cancer has been published by the World Health Organization (WHO 2003) . The extensive WHO classification includes criteria for all the expected diagnostic categories based on theoretical cell of origin and histological pattern. The INHAND classification generally adheres to this outline. However, the human classification includes the categories of Ductal and Lobular carcinoma which are convenient clinical designations but are not consistent with current concepts of origin (Cardiff and Wellings 1999) .
The largest single category in the WHO morphological classification is ''invasive ductal carcinoma not otherwise specified (NOS)'' (WHO 2003) . Recently, molecular classifications have been proposed for the clinical classification of human NOS or no-specific type (NST) breast cancer (Weigelt and Reis-Filho 2009) . These classifications are based on hierarchical analysis of expression microarrays. The most commonly used molecular classification of NST tumors recognizes five molecular subgroups: Luminal A, Luminal B, Her2 positive, and Normal and Basal cell (Sorlie et al. 2001) .
Most clinicians now find it beneficial to divide NST breast cancers into ERþ/PRþ, HER2þ, and triple negative. This convenient clinical classification has dictated clinical management of human breast cancer over the last decade because ER and HER2 are targetable proteins. However, the triple negative tumor phenotype (TNP) was almost immediately recognized as a morphologically and clinical diverse group of human tumors (Rakha et al. 2007 ). The identification of ''basal'' biomarkers in some triple negative tumors led to a general assumption that they are synonymous. Moreover, the basal cell concept has been challenged as an untenable misinterpretation of the biology that should be discarded (Rakha, Reis-Filho, and Ellis 2008; Gusterson et al. 2005; Lavasani and Moinfar 2012) . Most analyses are finding heterogeneity within any given group. A new term has been introduced, ''luminobasal,'' which is designed to reflect this heterogeneity (Balko et al. 2012) . The above exemplifies the confusion that reigns in the current classifications of human breast cancer. The ''lumping'' of clinical outcomes with expression profiles circumvents the traditional morphological classifications. Only early efforts have started that match the morphology with the molecular information; therefore, the confusion will likely increase. In short, the definitive molecular classification of human breast cancer is yet to emerge.
The use of expression microarrays for clinical classifications has encouraged attempts to classify mouse mammary tumors with the same expression technology (Herschkowitz et al. 2007 ). Since the vast majority of mouse tumors promoted by the MMTV-LTR do not express ER, PR, or Her2, they could all fall into the ''triple negative'' or basal category of human NST breast cancer (Weigelt and Reis-Filho 2009) . These attempts to match mouse and human molecular expression profiles have not included rigorous efforts to match histological patterns with the expression profiles. Attempts to match the human molecular categories also ignore the rich variation in GEM tumors leading to a potentially misleading grouping of genotypes. The challenge for the next iteration of INHAND will be to anticipate the movement toward molecular classifications of breast cancers and to harmonize them with the traditional structure-based classifications. At the end of this article, we include examples of several GEM tumors.
RAT MODELS
Evaluation of mammary gland toxicity in rats is critical in toxicity testing. The rat in many cases may be the only toxicology animal model studied that uses sexually mature animals and is dosed at intervals ranging from a single day to a lifetime in length.
Acute to chronic bioassays conducted by industry and agencies such as the National Toxicology Program remain a standard approach for pharmaceutical safety assessment and chemical hazard identification (Davis and Fenton 2013) . Industry-sponsored studies generally use the F344, Sprague-Dawley (SD), Harlan Sprague-Dawley, or Wistar rats, the latter three most common today. The importance of rat strain selection is demonstrated by their differences in susceptibility to both non-neoplastic and neoplastic changes. For example, mammary gland fibroadenomas are the most common spontaneous tumor in female SD rats, with incidences reported as high as 70% in chronic studies. In contrast, female Fischer rats have reported incidences of about 40%. This is also important in human risk assessment. Fibroadenomas are not considered a premalignant lesion in humans nor are rat mammary fibroadenomas considered predictive of carcinoma in women. In contrast, spontaneous mammary adenocarcinomas are considered relevant in studies and are at a higher spontaneous incidence in studies using the SD rat as compared to the F344 rat (Davis and Fenton 2013) .
Genetic susceptibilities of the various species and strains of rodents have been exploited in the development of animal models for mammary gland cancer. For example, spontaneous mammary gland cancers in rats, generally adenocarcinomas, can be enhanced with treatment with genotoxic carcinogens like DMBA, N-nitrosomethylurea, and Nethyl-N_nitrosourea (ENU). These induced mammary tumors are hormone-dependent and can be modulated by a number of factors including reproductive status, hormone treatment, diet, and the dose and timing of carcinogen administration (Davis and Fenton 2013) .
As is the case for mice, differences in the development and physiology of the rat require understanding for accurate human risk assessment. For example, as virgin female SD and F344 rats become middle aged (from 8 to 14 months of age), normal reproductive senescence ensues and there is an increasing level of prolactin (PRL) secretion that contributes to the development of a number of spontaneous morphologic changes. These include increased secretions, duct dilation, alveolar and tubular epithelial hyperplasia, and periductal fibrosis. Xenobiotics that increase pituitary PRL secretion like dopamine receptor antagonists can also cause these rat mammary gland changes. In contrast, dopamine agonists may reduce PRL and decrease the incidence of the above histologic changes as well as the incidence of spontaneous mammary gland neoplasia. Hyperprolactinemia is not normal in postmenopausal women. Therefore, while the histologic changes of senescence in rats are a normal age-related change, histologic changes similar to those observed in women would be considered dysplastic (Davis and Fenton 2013) .
MORPHOLOGY

Mammary Gland
Embryologic development of the rat and mouse mammary gland has been investigated extensively and will only be briefly considered here (for reviews, see Ceriani 1970; Knight and Peaker 1982; Russo, Tewari, and Russo 1989) . The male and female rat and mouse mammary gland develops from a single layer of cuboidal epithelium originating from the milk bud that forms the primitive nipple, progressing in a cephalocaudal sequence (Myers 1917; Cardiff and Wellings 1999) . Islands of epithelium thicken into hillocks of cuboidal cells resting on an indistinct basal membrane; simultaneously, there is atrophy of the epithelial cells between the hillocks (Myers 1917 ). In the male or female fetus, mammary glands remain as rudimentary buds of epithelium without development into distinct lobules or alveoli (Knight and Peaker 1982) .
In the rat and mouse, the development and function of the mammary gland is directed by numerous hormones including estrogens, androgens, progesterone, PRL, growth hormone (GH), insulin, catecholamines, and adrenocorticotropic hormone (ACTH) (Russo and Russo 1996) . Androgens initiate differentiation of the male phenotype by promoting atrophy of the rudimentary buds in the male (Goldman, Shapiro, and Neumann 1976; Sourla, Martel, et al. 1998; Sourla, Flamand, et al. 1998) . This atrophy of the buds is triggered by testosteroneinduced condensation of the stroma (Topper and Freeman 1980) . Mammary gland morphology in the male rat is altered to the morphology of the female rat if androgens are eliminated, and androgens administered to female rat fetuses cause mammary glands to appear male-like (Goldman, Shapiro, and Neumann 1976) . This does not occur in the mouse, because of a loss of androgen responsiveness. PRL is also an important pituitary hormone controlling rodent mammary gland growth. While the precise roles of estrogens (E) and progesterone (P4) in the rat fetus are less clear, studies in mice and ex vivo mammary gland explants suggest that progesterone is not critical to embryonic development of mammary glands in mice and its absence in utero does not affect the potential for maturation in adulthood (Freeman and Topper 1978) . Estrogens promote mammary gland development in the mouse fetus; however, E inhibits development in the rat fetus (Ceriani 1970) .
The neonatal male and female rat and mouse have 6 and 5 pairs of glands, respectively, with a single, central lactiferous duct, several branching secondary ducts, and numerous tertiary ducts (Ceriani 1970; Cardiff and Wellings 1999) . In the rat, the glands are distributed in pairs along the milk line, with 1 pair cervical, 2 thoracic, 1 abdominal, and 2 inguinal (Astwood, Geschickter, and Rausch 1937) . Distribution in the mouse is in the neck, chest wall (2 pairs), abdominal wall, and inguinal region (Cardiff and Wellings 1999) . Mammary tissue is embedded in a mass of adipocytes, pre-adipocytes, and fibroblasts, referred to as the fat pad, with a thin layer of stroma separating the epithelial cells from the fat pad (Hovey, McFadden, and Akers 1999; Imagawa et al. 2002; Silberstein 2001) . For toxicology studies, it is common to include a regional lymph node in the section for which important histologic changes may be observed (Figures 1-3 ). In the prepubescent female rat, mammary growth is mainly influenced by GH and PRL with minimal influences of estradiol (E2) and P4 (Knight and Peaker 1982) .
Mammary growth in the male and female mouse and rat during puberty is dependent on normal gonadal function, as indicated by the absence of development in ovariectomized or gonadectomized rats (Cowie and Folley 1961) . While a detailed description of pubescent mammary gland development in males is not published, in females, growth of the mammary gland during puberty is characterized by differentiation of the epithelium into terminal end bud units (TEBs), rapid expansion by elongation and branching of the ducts, and hypertrophy of the fat pad (Cowie and Folley 1961; Russo, Tewari, and Russo 1989; Knight and Peaker 1982; Cardiff and Wellings 1999) . New end buds form from lateral branching of mature ducts and have the potential to Vol. 40, No. 6S, 2012 DIAGNOSTIC TERMINOLOGY OF THE MAMMARY GLAND 11S form lobules. The TEBs are the major hormone sensitive area of the mammary glands for sexually mature rats and mice. PRL, estrogen, and progesterone are the predominant hormones controlling rodent TEB development to lobular alveolar structures in the virgin rodent (Richards et al. 1983 ). In rats, these hormones are also important in influencing adult mammary gland morphology (Rudmann et al. 2005; Lucas et al. 2007 ). As discussed earlier, androgens contribute to the development of both the rat and the mouse mammary gland, and in the adult rat, androgens produced by the ovary effect mammary gland morphology in both the male and the female. Effects of androgens are modulated by the androgen receptor, which is upregulated with androgen stimulation as well as by the erbB family of growth factors (epidermal growth factors).
In female rats and mice, ducts, ductules, and alveoli are lined by 1 or 2 layers of epithelial cells and surrounded by myoepithelial cells. Within these epithelial structures are 3 types of epithelial cells: clear cells, dark cells, and intermediate cells. The morphologic differences between these cell populations are the result of variability in the number of ribosomes, mitochondria, lipid droplets, and secretory vacuoles (Greaves 2007) . The rat mammary gland is sexually dimorphic (Figures 4 and 5; Lucas et al. 2007) . In contrast to female rats, ducts in male rats are infrequent and when observed are lined by a stratified epithelium consisting of vacuolated tall cuboidal to short columnar epithelial cells. Alveoli are predominant in the male and also lined by a stratified epithelium. Imbalance of mammotrophic hormones like PRL, estrogens, and androgens may result in the male and female rat mammary gland converting to the morphologic appearance expected of the opposite sex (Rudmann et al. 2005; Lucas et al. 2007 ).
Degenerative Changes
Degeneration: Ductular/Alveolar Epithelium Pathogenesis/cell of origin: Ductular, alveolar epithelial cell; myoepithelial cell.
Diagnostic features
Epithelial cells swollen Epithelial vacuolization/bleb formation Loss of organization of the cell layers Dilatation (ectasia) of alveoli or ducts with accumulation of secretory material Differential diagnoses Postmortem autolysis: Uniform dissolution of entire tissue with no change in organization or depth of cell layers Atrophy: Thinning of affected ducts or alveoli Comment: Degenerative changes in the mammary gland are rare but can be observed with toxic agent exposure and as a consequence of aging. Surrounding tissues such as the fat pad, skin, and local lymph nodes can also undergo a variety of degenerative changes. Adjacent to or within areas of degenerating, necrotic, hyperplastic, or metaplastic epithelium Differential diagnoses Hypertrophy/Hyperplasia: Epithelium is thickened due to increased numbers or size of cells, resulting in undulating, rugose epithelial surface and irregular arrangement of cell layers (see proliferative lesion section of this document) Neoplasia: Expansile nodule usually protruding into cavity, with cellular atypia and compression of adjacent structures (see proliferative lesion section of this document) Comments: Basophilia is recommended as the preferred descriptive term for the lexicon. When basophilia is interpreted as evidence for regeneration (growth of cells and tissues to replace lost or damaged structures, as opposed to hypertrophy/hyperplasia), it is recommended that this interpretation be included in the text of the report (Kumar et al. 2010) . Irregularity of epithelial cell arrangement may be observed in the ductular or alveolar epithelium in the process of regeneration. Degeneration, necrosis, and regeneration are often present together in mammary gland repeatedly injured by toxicants. See comments above in sections on degeneration and necrosis.
Inflammatory Changes
While inflammation of the mammary gland is an important cause of morbidity in large animal veterinary species, because of animal husbandry procedures, inflammation of the rodent mammary gland is uncommon. More commonly, histological changes are limited to infiltrates of foci of lymphocytes, neutrophils, macrophages, or plasma cells, alone or in combination.
Infiltrate: Lobule
Pathogenesis/cell of origin: Alveolar or ductular epithelium and associated tissues.
Diagnostic features
Infiltration of a relatively pure population of lymphocytes, plasma cells, neutrophils, eosinophils, macrophages or a mixture of these cell types into the lamina propria of the lobule and associated tissues Differential e.g., fungi, mycobacteria, or foreign body (Kumar et al. 2009 ). Granulomatous inflammation is commonly seen in rats associated with rupture of a dilated duct. It is important to differentiate foreign body inflammation from other inflammatory lesions, because of the differences in their causes. Chronic inflammation may have different characteristics depending on the longevity of the lesion and the initiating cause. While it is uncommon in the rodent mammary gland, it may also occur as a result of leakage of secretory material outside the ducts.
Fibrosis: Lobule (Figure 7)
Pathogenesis/cell of origin: Fibroblasts or periductular fibroblasts.
Diagnostic features
Increased thickness in the connective wall of mostly medium size ducts Usually periductular Differential diagnosis Fibrosis in chronic inflammation Comment: Fibrosis in periductular regions is commonly seen in aged rats and it is recommended that periductular be used as a modifier.
In BALB/c mice treated with EGF, the most evident histological feature is proliferation of small and medium size ducts. This proliferation is associated with an evident increase in the interlobal connective tissue as well as periductal fibrosis (Molinolo et al. 1998 (Korenaga et al. 2004) but has only been rarely described in the literature in the mammary gland of rodents (Beems, Gruys, and Spit 1978) . A severity score that reflects the extent of amyloid deposits in each tissue of affected mice is not generally considered useful. It is recommended that when amyloid is observed in the mouse mammary gland, that ''present'' is used as a descriptor. Male rats or mice: If due to effects of decreased androgens or emaciation, there are smaller and/or decreased number of alveolar profiles Female rats: Tubulo-alveolar profiles present but in decreased numbers or have thinned epithelium Tubular or alveolar lumina may appear dilated Relative amount of fat pad increased Differential diagnoses Hypoplasia: Tubular and alveolar profiles present but in decreased numbers due to developmental anomaly Artifact: Decreased glandular tissue may result from variability in gross necropsy, trimming, and sectioning procedures. Comments: Feminization is not a recommended term because it is syndromic, only applies to the male rat, and may be misleading because of its use in humans. In male rats, xenobiotics that increase PRL will result in atrophy of alveoli resulting in a tubulo-alveolar appearance of the gland similar to what is observed in the normal virgin female gland ( Figure 15 ; Ose et al. 2009; Lucas et al. 2007 ). In both males and females, xenobiotics may perturb the hypothalamic-pituitary-gonadal axis resulting in a decrease in circulating, mammotrophic hormones resulting in glandular atrophy. Inconsistent sectioning of the mammary gland may result in the erroneous diagnosis of atrophy.
Hypertrophy/hyperplasia, alveolar and/or ductal epithelial cell: lobule ( Figure 16 ) Synonyms: Masculinization, virilization (female rat) Pathogenesis/cell of origin: A decrease in the estrogen:androgen balance in the female rat may result in the tubulo-alveolar appearance of the normal female mammary gland to become more malelike (lobulo-alveolar). Presumably there may be other causes of alveolar/ductal epithelial hypertrophy and hyperplasia. Adult mouse mammary glands are not androgen responsive.
Reflect what is observed in the normal male mammary gland and include:
An increased predominance of irregular nests of alveolar epithelial cells often not associated with a clear duct versus the ductal dominant histology (so-called tubulo-alveolar) observed in a normal female mammary gland Increased alveolar cell size and abundance of cytoplasm Cytoplasmic basophilia and vacuolation A pseudostratified appearance to alveolar and ductal epithelium Increased abundance of cytoplasm May have increased ductular or alveolar secretions Differential diagnoses Hyperplasia, lobuloalveolar: The distinct tubuloalveolar architecture of the female is maintained (predominance of ducts associated with small nests of alveoli). There is a normal relationship between hyperplastic alveolar epithelial cells and associated ducts. Increase in profiles of alveoli around a duct without cytologic changes in individual alveolar or ductal cells (increased cytoplasm, vacuolation, basophilia, pseudostratification). Comments: Neither masculinization nor virilization are recommended for use because they are syndromic terms and may be misleading because of their implications in humans. In female rats, xenobiotics that cause an increase in androgens or decrease the estrogen:androgen ratio may induce an alteration in the mammary gland characterized by hypertrophy and hyperplasia of alveolar and ductal epithelium resulting in a lobulo-alveolar appearance more like the normal male mammary gland (Lucas et al. 2007; Rudmann et al. 2005 (Cardiff and Kenney 2007) . Thelma Dunn grouped tumors into Types A, B, C, and P (microacinar, ductal, and pregnancy-dependent). This classification was based on MMTV-induced ''spontaneous'' mammary tumors that are now known to be related to insertion activation of Wnt, Fgf, and Notch genes .
Adenocarcinoma arising in fibroadenoma: mammary gland ( Figure 28A (Cardiff 2010; Radaelli et al. 2009 ). However, these tumors have been identified as a distinct tumor arising from EMT with tumor cell loss of oncogene addiction or loss of or mutation of p53 (Damonte et al. 2007; Debies et al. 2008) . The EMT tumor phenotype is characterized by a predominance of spindle cells which stain for both epithelial and mesenchymal markers (Damonte et al. 2007 ). The phenotype is now recognized in the human molecular classifications as a rare ''Claudin Low'' tumor (Herschkowitz et al. 2012) .
ZYMBAL'S GLAND
The Zymbal's or auditory sebaceous gland is most commonly described in rats. However, a small auditory sebaceous gland is also present in mice (Seely and Boorman 1999) . In rats, the gland is 3 to 5 mm in diameter and located anterior-ventral to the ear canal. It is composed of 3 to 4 lobules, each with an intralobular duct emptying into an excretory duct which empties into the ear canal. There are two smaller sebaceous glands underlying the epithelium of the ear canal which are included as part of the Zymbal's gland by some. These are holocrine glands where the secretion is formed by mature acinar cells degenerating to become the secretory product (Haines and Eustis 1990; Nielsen 1978) . Spontaneous tumors are occasionally seen and have also been induced by chemical carcinogens.
Degenerative, inflammatory, vascular, and other nonneoplastic changes observed in Zymbal's gland are largely similar to those observed in the mammary gland. Specific examples of these non-neoplastic changes are displayed in Figures 30 and 31 Hyperplasia: Epithelium is thickened due to increased numbers of cells, resulting in undulating, rugose epithelial surface and irregular arrangement of cell layers (see proliferative lesion section of this document) Neoplasia: Expansile nodule usually protruding into cavity, with cellular atypia and compression of adjacent structures (see proliferative lesion section of this document) Comments: Basophilia is recommended as the preferred descriptive term for the lexicon. When basophilia is interpreted as evidence for regeneration (growth of cells and tissues to replace lost or damaged structures, as opposed to hyperplasia), it is recommended that this interpretation be included in the text of the report (Kumar et al. 2010) . Irregularity of epithelial cell arrangement may be observed in the ductular or sebaceous epithelium in the process of regeneration. Degeneration, necrosis, and regeneration are often present together in Zymbal's glands repeatedly injured by toxicants.
Inflammatory Changes
Inflammation of the Zymbal's gland is uncommon. More commonly, histological changes are limited to infiltrates of foci of lymphocytes, neutrophils, macrophages, or plasma cells, alone or in combination.
Infiltrate: Zymbal's Gland (Figure 30) Pathogenesis/cell of origin: Sebaceous or ductular epithelium and associated tissues Diagnostic features Infiltration of a relatively pure population of lymphocytes, plasma cells, neutrophils, eosinophils, macrophages, or a mixture of these cell types into the lamina propria of the lobule and associated tissues Differential diagnoses Inflammation Hematopoietic neoplasia: Homogenous lymphocyte population infiltrating entire tissue and other sites Comment: The base term infiltrate is recommended followed by the predominant cell type or ''mixed'' if there is not a predominant cell type. Leukocytic infiltrates consisting only of lymphocytes or plasma cells may indicate an immunologic effect of a xenobiotic but can also be observed as a spontaneous change.
Other Changes
Dilation: Zymbal's Gland (Figure 31 ) PREPUTIAL/CLITORAL GLAND Preputial and clitoral glands are found in both rats and mice. They are paired modified sebaceous glands located in the inguinal region adjacent to the penis and vagina respectively ( Figure 33 ). In males, the preputial gland empties into the preputial cavity and in females, the clitoral gland duct empties into the clitoral fossa. The growth and secretory activity of preputial and clitoral glands are regulated primarily by testosterone and the pituitary hormones, ACTH, GH, and PRL. Administration of testosterone, but not estrogens, to male or female rats causes hypertrophy and hyperplasia of acinar cells. Castration of adult male rats results in atrophy. In rats, large intracytoplasmic eosinophilic granules are a prominent feature. These granules contain pheromones (aliphatic alcohols) and beta-glucuronidase and are not present in mice. Degenerative, inflammatory, vascular, and other non-neoplastic changes observed in preputial/clitoral glands are largely similar to those observed in the mammary gland. Specific examples of these non-neoplastic changes are displayed in Figures 34 and 35 When basophilia is interpreted as evidence for regeneration (growth of cells and tissues to replace lost or damaged structures, as opposed to hyperplasia), it is recommended that this interpretation be included in the text of the report (Kumar et al. 2010) . Irregularity of epithelial cell arrangement may be observed in the ductular or sebaceous epithelium in the process of regeneration. Degeneration, necrosis, and regeneration are often present together in preputial/clitoral glands repeatedly injured by toxicants.
Inflammatory Changes
Inflammation of the preputial or clitoral glands is uncommon. More commonly, histological changes are limited to infiltrates of foci of lymphocytes, neutrophils, macrophages, or plasma cells, alone or in combination. In male mice, inflammation of the preputial gland can be a consequence of fight wounds in gang-housed mice. 
